Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

Oncology API Products

Oncology API Products

Oncology API Products
Oncology API Products

Oncology/Anticancer API Products Manufacturer and Supplier

Dr. Reddy's is a global leader in developing APIs in the Oncology/Anti-cancer therapy area, with deep technical and scientific knowledge established over decades. With a strong presence across six continents and 39 countries, we are a partner of choice for supplying APIs to leading oncology formulators globally.

As one of the largest generic pharmaceutical manufacturers in the world, we have established a niche in generic oncology APIs and partner of choice for supplying APIs to leading oncology formulators globally.

Our various classes of API under anti-cancer portfolio are as follows:

Kinase Inhibitors

Kinase Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

BCL-2 Inhibitor

BCL-2 Inhibitor - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Androgen Receptor (AR) Inhibitors

Androgen Receptor (AR) Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Folate Analog Metabolic Inhibitors

Folate Analog Metabolic Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Nucleoside Metabolic Inhibitors

Nucleoside Metabolic Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Microtubule Inhibitors

Microtubule Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Proteasome Inhibitors

Proteasome Inhibitors - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Thalidomide Analogue

Thalidomide Analogue - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

CYP17 Inhibitor

CYP17 Inhibitor - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Bifunctional Mechlorethamine

Bifunctional Mechlorethamine - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Nucleoside Metabolic Inhibitor

Nucleoside Metabolic Inhibitor - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Alkylating Agent

Alkylating Agent - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Poly (ADP-ribose) Polymerase

Poly (ADP-ribose) Polymerase - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

CXCR4 Chemokine Receptor

CXCR4 Chemokine Receptor - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

GnRH Receptor Antagonist

GnRH Receptor Antagonist - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Chemical Permeation Enhancer

Chemical Permeation Enhancer - Dr. Reddy's

*Countries referred in the above graphic denotes DMF filing geographies

Dr. Reddys Portfolio of Anti-cancer APIs

We manufacture our Anti-cancer APIs at cGMP API manufacturing facilities which are successfully inspected by international regulatory authorities such as the USFDA, EMEA, ANVISA, PMDA, and Health Canada.

Our team of process experts draws on their integrated understanding of IP, process development (API and formulation), and API manufacturing to ensure that by design, the process is lean, free from potential genotoxic impurities, and scalable to manufacture for early market entries. This is of particular importance to select the optimal synthesis route in the context of the IP situation. Other aspects are the solid-state forms and particle characteristics that are critical in formulation development.

We have incorporated sensitive and rigorous analytical methods to control the impurities at a specified level and extensively studied the flow properties, crystal size/shape, and morphology in accordance with future requirements. In addition, our APIs have been designed to address customized PSD requirements through size reduction and crystallization techniques, resulting in a high probability of successful formulation development.

USPs of our Anti-cancer APIs

  • QbD approach for an efficient process & high-quality output
  • Availability of APIs in various forms.
  • cGMP API manufacturing facility - Successfully inspected by international regulatory authorities.
  • GTIs & impurities are controlled below the TTC limit & ICH limits, respectively.
  • Formulation dossier filed across all major markets.
  • Regulatory filing available across the globe.
  • Completely backward integrated on the Key starting materials to ensure uninterrupted supplies.
  • Adequate capacity to meet the global demands.
  • KSM suppliers with timely deliveries and adherence to stringent specifications.
  • Process safety management guidelines are implemented to enable a sustainable product supply.
  • IP-Compliant API that meets regulatory requirements.
Anti-Cancer/ Oncology Products

Abiraterone Acetate

Therapy Area
Anti-Cancer/ Oncology

Apalutamide

Therapy Area
Anti-Cancer/ Oncology

Azacitidine

Therapy Area
Anti-Cancer/ Oncology

Bendamustine Hydrochloride

Therapy Area
Anti-Cancer/ Oncology

Bortezomib

Therapy Area
Anti-Cancer/ Oncology

Cabazitaxel

Therapy Area
Anti-Cancer/ Oncology

Cabozantinib S-Malate

Therapy Area
Anti-Cancer/ Oncology

Capecitabine

Therapy Area
Anti-Cancer/ Oncology

Carfilzomib

Therapy Area
Anti-Cancer/ Oncology

Dasatinib

Therapy Area
Anti-Cancer/ Oncology

Decitabine

Therapy Area
Anti-Cancer/ Oncology

Docetaxel

Therapy Area
Anti-Cancer/ Oncology

Enzalutamide

Therapy Area
Anti-Cancer/ Oncology

Eribulin Mesylate

Therapy Area
Anti-Cancer/ Oncology

Gemcitabine Hydrochloride

Therapy Area
Anti-Cancer/ Oncology

Ibrutinib

Therapy Area
Anti-Cancer/ Oncology

Icotinib Hydrochloride

Therapy Area
Anti-Cancer/ Oncology

Larotrectinib

Therapy Area
Anti-Cancer/ Oncology

Lenalidomide

Therapy Area
Anti-Cancer/ Oncology

Lenvatinib

Therapy Area
Anti-Cancer/ Oncology

Lomustine

Therapy Area
Anti-Cancer/ Oncology

Midostaurin

Therapy Area
Anti-Cancer/ Oncology

Nilotinib Hydrochloride

Therapy Area
Anti-Cancer/ Oncology

Olaparib

Therapy Area
Anti-Cancer/ Oncology

Palbociclib

Therapy Area
Anti-Cancer/ Oncology

Pazopanib

Therapy Area
Anti-Cancer/ Oncology

Pemetrexed Disodium (Amorphous)

Therapy Area
Anti-Cancer/ Oncology

Pemetrexed Disodium (Heptahydrate)

Therapy Area
Anti-Cancer/ Oncology

Pemetrexed Ditromethamine Dihydrate

Therapy Area
Anti-Cancer/ Oncology

Plerixafor

Therapy Area
Anti-Cancer/ Oncology

Pomalidomide

Therapy Area
Anti-Cancer/ Oncology

Relugolix

Therapy Area
Anti-Cancer/ Oncology

Ruxolitinib Phosphate

Therapy Area
Anti-Cancer/ Oncology

Salcaprozpate Sodium (SNAC)

Therapy Area
Anti-Cancer/ Oncology

Venetoclax

Therapy Area
Anti-Cancer/ Oncology

Explore other Therapeutic categories.

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit